icon-folder.gif   Conference Reports for NATAP  
  17th European AIDS Conference
November 6-9
2019, Basel
Back grey_arrow_rt.gif
Outcomes of antiretrovirals used as the third drug in subgroups of treatment na´ve individuals living with HIV
  17th European AIDS Conference, November 6-9, 2019, Basel
Reported by Jules Levin
A Mocroft1, B Neesgaard2,R Zangerle3, A Rieger4, A Castagna5, V Spagnuolo5, A Antinori6, F Lampe1, M Youle7, JJ Vehreschild8, C Mussini9, V Borghi9, J Begovac10, C Duvivier11, H GŘnthard12, A Rauch13, J Tiraboschi14, N Chkhartishvili15, N Bolokadze15, F Wit16,JC Wasmuth17, S De Wit18,C Necsoi18, C Pradier19, V Svedhem20, C Stephan21,H Garges22, F Rogatto23, Lars Peters2, L Ryom2 for the RESPOND study*
1University College London, London, UK.2CHIP, Rigshospitalet, Copenhagen, Denmark. 3Medizinische Universitńt Innsbruck, Innsbruch, Austria. 4MedizinischeUniversitńt Wien, Vienna, Austria. 5UniversitÓ Vita-Salute San Raffaele, Milano, Italy. 6IstitutoNazionale MalattieInfettiveLazzaro Spallanzani, Rome, Italy. 7Royal Free Hospital, London, UK. 8University Hospital Cologne, Cologne, Germany. 9UniversitÓ degli Studi di Modena, Modena, Italy. 10University Hospital of Infectious Diseases, Zagreb, Croatia. 11H˘pitalUniversitaireNecker, Paris, France. 12University of Zurich, Zurich, Switzerland. 13University Hospital Berne, Bern, Switzerland. 14PISCIS Cohort Study, Barcelona, Spain. 15Georgian National AIDS Health Information System, Tbilisi, Georgia. 16Stichting HIV Monitoring (SHM), Amsterdam, Netherlands. 17University Hospital Bonn, Bonn, Germany. 18Centre de Recherche en Maladies Infectieuses, Brussels, Belgium. 19UniversitÚ C˘te d'Azur et Centre Hospitalier Universitaire, Nice, France. 20Karolinska University Hospital, Stockholm, Sweden. 21Johann Wolfgang Goethe-University Hospital, Frankfurt, Germany. 22ViiVHealthcare, London, UK. 23Gilead Sciences, California, USA.





The International Cohort Consortium of Infectious Disease (RESPOND) has received funding from ViiV Healthcare LLC and Gilead Sciences. Additional support has been provided by participating cohorts contributing data in-kind and/or statistical support: Austrian HIV Cohort Study (AHIVCOS), The Australian HIV Observational Database (AHOD), CHU Saint-Pierre, University Hospital Cologne, The EuroSIDA cohort, Frankfurt HIV Cohort Study, Georgian National AIDS Health Information System (AIDS HIS), Modena HIV Cohort, San Raffaele Scientific Institute, Swiss HIV Cohort Study (SHCS), Royal Free HIV CohortStudy. *https://www.chip.dk/Studies/RESPOND/Study-Group